MEDVi Weight Loss Review 2026: Pricing, Care and Customer Ratings

MEDVi review checked September 24, 2026. MEDVi advertises introductory pricing from $116/month for semaglutide and $166/month for tirzepatide, with regular price-lock rates of $166 and $199/month respectively. Its page does not make the promotion duration fully clear; verify the ongoing charge before enrollment.

By MEDVi Written by TirzaSema Editorial Team Fact-checked Updated
MEDVi logo

Quick verdict

Independent review of

MEDVi glp1.medvi.org

  • Official prices checked September 24, 2026
  • No affiliate relationship
  • Compounded medication: not FDA-approved
Official site ↗
Best for
Cash-pay patients who value flat advertised pricing and round-the-clock support
Starting price
$116/mo
Key feature
Price-lock advertising, physician review and support with medication delivery

MEDVi advertises introductory pricing from $116/month for semaglutide and $166/month for tirzepatide, with regular price-lock rates of $166 and $199/month respectively. Its page does not make the promotion duration fully clear; verify the ongoing charge before enrollment.

Our rating

  • Cost and price transparency8.0/ 10

    Published rates and total-cost visibility are assessed, including separate fees and commitment terms.

  • Medication options and sourcing4.0/ 10

    We distinguish FDA-approved medicines from compounded options and score range and clarity accordingly.

  • Medical care and safety6.0/ 10

    We assess clinician involvement and public safety information; this is not a clinical efficacy rating.

  • Ease of use and access8.0/ 10

    We consider virtual access, eligibility friction, availability and treatment workflow.

  • Customer support and policies8.0/ 10

    We consider published support policies and broad customer feedback; reviews are not clinical evidence.

How this score is calculated

Each category score is converted to a percentage and multiplied by its weight. The overall score is the sum of those contributions.

CategoryScoreWeightContribution
Cost and price transparency8.0 / 1030.0%2.4
Medication options and sourcing4.0 / 1020.0%0.8
Medical care and safety6.0 / 1020.0%1.2
Ease of use and access8.0 / 1015.0%1.2
Customer support and policies8.0 / 1015.0%1.2
Overall6.8 / 10

Pricing

Compounded semaglutide injection (introductory)

$116/mo
  • Promotional advertised starting rate; regular price listed as $166/month
Check current terms

Compounded tirzepatide injection (introductory)

$166/mo
  • Promotional advertised rate; regular price listed as $199/month
Check current terms

Compounded tirzepatide injection (regular)

$199/mo
  • Price-lock rate advertised; clinician review and medication delivery
Check current terms

Prices can change. Check the official site for current details. Last checked September 24, 2026.

Pros and cons

Pros

  • Publishes advertised and ongoing monthly rates
  • No insurance or membership fee is listed
  • Provider review, delivery and 24/7 support are advertised

Cons

  • Compounded GLP-1s are not FDA-approved
  • Marketing displays both promotional and regular rates
  • Trustpilot is for MEDVi as a company, not a specific medication or clinical outcome

Features

Provider reviewOnline health intake reviewed by provider
Medication deliveryIncluded in advertised monthly price
Dietitian and coachingAdvertised; confirm visit limits
Price lockRegular prices advertised as locked
Compounded GLP-1sNot FDA-approved
InsuranceCash-pay advertised

Specifications

MEDVi Weight Management specifications
Service typeOnline clinician-evaluated weight-management service
Semaglutide$116 advertised introductory; $166 regular monthly price
Tirzepatide$166 advertised introductory; $199 regular monthly price
Medication typeCompounded GLP-1; not FDA-approved
MembershipNo membership or hidden fees advertised
Support24/7 support, coaching and dietitian visits advertised
Trustpilot4.3 / 5 from 14,733 reviews on Trustpilot (checked September 24, 2026)
Data statusProgram page and Trustpilot checked September 24, 2026

Full review

Price checked 26 days ago

Our score
6.8/10
Best for
Cash-pay patients who value flat advertised pricing and round-the-clock support
Starting price
Promotional starts: semaglutide $116 and tirzepatide $166/month; regular listed price-lock rates are $166 and $199/month.
Trustpilot
4.5/5; 14813 reviews

Quick verdict

MEDVi markets a cash-pay telehealth program with physician review, home delivery and continuous support. Its landing page prominently advertises lower starting prices and separately describes higher regular rates under a price-lock guarantee. We show both because the exact promotion duration is not clear from the page. The offered injections are compounded rather than FDA-approved finished drugs. Trustpilot ratings apply to MEDVi overall; customer opinions do not confirm clinical results. Research only, not hands-on testing.

Our rating

Weighted score: 6.8/10. Cost and price transparency 30%; medication options and sourcing 20%; medical care and safety 20%; ease of use and access 15%; customer support and policies 15%. The scoring evaluates the service and public information, not medication efficacy.

What it costs

How it works and what care includes

Start with an online health questionnaire or consultation. A licensed clinician makes the prescription decision based on medical history, state rules and individual appropriateness. The advertised offer and public information do not guarantee treatment or eligibility. Before paying, confirm the prescription type, dispensing pharmacy, shipping, dose, total payment, renewal and cancellation terms.

Medication, safety and sourcing

FDA-approved medicines have been reviewed by the FDA for their indicated uses. Compounded medicines are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality before marketing. FDA recommends compounded drugs only when a patient’s medical needs cannot be met by an FDA-approved drug. Ask the clinician what exact product and pharmacy would be used, and discuss risks with a licensed healthcare professional. This review does not provide medical advice.

What customers say

4.3out of 5 on Trustpilot14821 reviews, checked September 24, 2026
5★79%
4★5%
3★2%
2★2%
1★12%

What customers praise

  • Helpful and responsive staff
  • Convenient virtual appointments
  • Positive reports about clear explanations

What customers complain about

  • Some report refund or policy disputes
  • Some customers mention billing discrepancies
  • Review profile covers the full company

Customer reviews describe individual service experiences. They are not medical evidence.

Trustpilot ratings summarize customer-submitted experiences and can include services beyond weight care. They are not a measure of clinical safety or effectiveness.

How it compares

Compare the actual checkout total, medication type and follow-up care.
What mattersMEDViWhat to compare
Medication pricePromotional starts: semaglutide $116 and tirzepatide $166/month; regular listed price-lock rates are $166 and $199/month.Ask whether quoted price includes medication, clinical fee and delivery
Medication statusCompounded options are listed; not FDA-approvedCheck exact prescribed product and pharmacy
Ongoing carePrice-lock advertising, physician review and support with medication deliveryConfirm visit and messaging limits

Frequently asked questions

How much does MEDVi cost?
The page advertises semaglutide from $116/month and tirzepatide at $166/month, while also listing regular price-lock rates of $166 and $199. Confirm how long any introductory price lasts.

Are MEDVi compounded GLP-1s FDA-approved?
No. Compounded drugs are not FDA-approved or reviewed by FDA for safety, effectiveness or quality before marketing.

Does MEDVi require insurance?
No insurance is advertised as required; the program is cash-pay.

Does MEDVi include medical support?
The site advertises provider review, coaching, dietitian visits and 24/7 support. Confirm what is included in the selected plan.

How we tested and scored

We reviewed the provider’s public program and pricing pages, checked customer-review pages where available, and compared fees, medication sourcing disclosures, care access and support against the TirzaSema GLP-1 Provider Scoring Methodology. We did not enroll, purchase medication or test treatment. Prices and review counts were checked September 24, 2026; promotional offers can change. Our score is an editorial assessment using the published weighted categories, not a medical recommendation. TirzaSema has no affiliate relationship with this provider.

Final verdict

MEDVi advertises introductory pricing from $116/month for semaglutide and $166/month for tirzepatide, with regular price-lock rates of $166 and $199/month respectively. Its page does not make the promotion duration fully clear; verify the ongoing charge before enrollment. This page is based on public information, not hands-on testing. Read our review methodology.

Alternatives

Trimi logo
Editor's choice

Trimi offers online provider review and bundled compounded GLP-1 plans. Its lowest advertised monthly rates require substantial prepaid commitments. Trustpilot currently displays a guidelines-breach…

September 24, 2026 7.9/10

Frequently asked questions

The page advertises semaglutide from $116/month and tirzepatide at $166/month, while also listing regular price-lock rates of $166 and $199. Confirm how long any introductory price lasts.

No. Compounded drugs are not FDA-approved or reviewed by FDA for safety, effectiveness or quality before marketing.

No insurance is advertised as required; the program is cash-pay.

The site advertises provider review, coaching, dietitian visits and 24/7 support. Confirm what is included in the selected plan.

Sources

  1. MEDVi GLP-1 program MEDVi · checked September 24, 2026
  2. MEDVi reviews Trustpilot · checked September 24, 2026
  3. FDA concerns with unapproved GLP-1 drugs FDA · checked September 24, 2026

How we test

TirzaSema GLP-1 Provider Scoring Methodology

This methodology explains how TirzaSema scores GLP-1 telehealth providers and programs. Scores are a weighted average of five categories, and every review shows the full breakdown. Affiliate relationships and commission rates are not part of the methodology.

  • Cost and price transparency (30%): total monthly cost at common doses, including membership, consultation and shipping fees, and how clearly this is shown before payment.
  • Medication options and sourcing (20%): FDA-approved brand-name and/or compounded options, how clearly compounded products are labeled, and dispensing-pharmacy information.
  • Medical care and safety (20%): eligibility assessment, licensed-clinician review, dose and side-effect monitoring, and follow-up care.
  • Ease of use and access (15%): sign-up process, time to treatment, states served, and insurance support.
  • Customer support and policies (15%): responsiveness, cancellation and refund terms, auto-renewal clarity, and patterns in public customer feedback.

We research prices using provider and manufacturer public pages. Where published, we separate medication, membership, consultation and shipping charges, note dose or term differences, and label introductory offers. Each review states when its sources were checked. We have not enrolled in or bought a service unless that specific review explicitly describes hands-on testing. Confirm current terms and eligibility with the provider.

FDA-approved medications are reference entries with their labeled uses and official manufacturer information; our provider ratings do not measure a treatment’s clinical effectiveness.

Some links on TirzaSema are affiliate links. Commissions never affect scores, rankings, pros and cons, or medical and regulatory information. See our Affiliate Disclosure.

Read the full methodology

Final verdict

MEDVi advertises introductory pricing from $116/month for semaglutide and $166/month for tirzepatide, with regular price-lock rates of $166 and $199/month respectively. Its page does not make the promotion duration fully clear; verify the ongoing charge before enrollment. This evaluation is based on public information and does not constitute medical advice.

MEDVi Weight Management

$116/mo

Visit MEDVi
T
Written by

TirzaSema Editorial Team

Research and editorial team

The TirzaSema Editorial Team researches U.S. GLP-1 prices and telehealth programs using official manufacturer, FDA and provider sources. Every review states whether it is based on hands-on testing or on research of public information,…